Health
Special formulation of inhaled niclosamide may be effective against SARS-CoV-2 – News-Medical.Net
Now in new research published on the preprint server bioRxix*, a novel formulation of the drug Niclosamide (NIC) is observed to be effective against SARS-CoV-2 and MERS-CoV in mouse models; it also protects against methicillin-resistance Staphylococcus aureu…
Healthcare systems worldwide are overwhelmed by the raging COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As the current number of global infections of SARS-CoV-2 nears 33 million individuals, an effective treatment or vaccine option is crucial and desperately needed.
The SARS-CoV-2 virus is related to the earlier coronaviruses of SARS-CoV and the Middle East respiratory syndrome-related coronavirus (MERS-CoV). Now in new research published on the pre…
-
General10 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
General24 hours agoCool weather sets cherry crops ‘weeks’ behind schedule in lead-up to Christmas
-
Business22 hours ago3 ASX stocks I’d trust with $10,000 for the next decade
-
Noosa News13 hours agoNSW records 100th e-rideable battery fire for 2025, prompting renewed safety calls